Concepedia

Yestle Kim

YK

Statistics

Publications

3

Citations

46

H-Index

3

Active since

2023

Affiliations

Madrigal Pharmaceuticals (United States)(Current)

Yestle Kim is an author at Madrigal Pharmaceuticals (United States).

Publications per year

2023–2024

3

Publications

3

Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis

Joseph F. Merola, Daniel Butler, Thomas Mark et al. · JAMA Dermatology · 2023 · 20 citations · Full text

Cost burden of cirrhosis and liver disease progression in metabolic dysfunction–associated steatohepatitis: A US cohort study

Jesse Fishman, Christina Qian, Yestle Kim et al. · Journal of Managed Care & Specialty Pharmacy · 2024 · 14 citations · Full text

Budget impact of resmetirom for the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)

Jesse Fishman, Yestle Kim, Hélène Parisé et al. · Journal of Medical Economics · 2024 · 12 citations · Full text

1–3 of 3